Stock ZEOX ZEO SCIENTIFIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Zeo ScientifiX, Inc.

Equities

ZEOX

US68621D2062

Market Closed - OTC Markets
Other stock markets
 19:52:03 01/07/2024 BST 		5-day change 1st Jan Change
1.43 USD -25.65% Intraday chart for Zeo ScientifiX, Inc. -21.43% +40.20%
06-14 Zeo ScientifiX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024 CI
06-03 Zeo Scientifix, Inc. Announces Management Changes CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zeo ScientifiX, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024
Zeo Scientifix, Inc. Announces Management Changes
Zeo Scientifix, Inc. Announces Chief Executive Officer Changes
Zeo ScientifiX, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
Zeo ScientifiX, Inc. has Changed its Ticker to ZEOX from OCEL
Zeo ScientifiX, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
An unknown buyer acquired Laboratory Facility Located in Basalt, Colorado from Organicell Regenerative Medicine, Inc. for $1.25 million.
Organicell Regenerative Medicine, Inc. Reports Interim Results of Phase 1/2A Research Program
Organicell Regenerative Medicine, Inc. Announces Resignation of Maria Ines Mitrani as Director
Organicell Welcomes Howard Golub as Its New EVP/CSO
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
Organicell Regenerative Medicine, Inc. Announces Executive Changes
Organicell Regenerative Medicine, Inc. Announces Management Changes
Organicell Regenerative Medicine, Inc. Terminates Albert Mitrani as Its Executive Vice President of Sales
Organicell Regenerative Medicine, Inc. Announces Termination of Dr. Maria Ines Mitrani as its Chief Scientific Officer
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Full Year Ended October 31, 2022
Organicell Regenerative Medicine, Inc. Reports Earnings Results for the Full Year Ended October 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZEOX Stock
  4. News Zeo ScientifiX, Inc.
  5. Other languages